Oasmia Pharmaceutical AB
OASM
OASM
Insider Trading Activity
Insider activity signals
0 activity signals detected for Oasmia Pharmaceutical AB
Insider trades have not triggered unusual activity signals for this company.
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2022-03-25 | 2022-03-22 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
70,819
83.66
SEK3,586,129 |
70,819 | 83.66 | SEK3,586,129 | |
| 2022-03-24 | 2022-03-22 | B Purchase |
Member of the Board of Directors Director |
77,840
33.71
SEK4,706,990 |
77,840 | 33.71 | SEK4,706,990 | |
| 2021-08-19 | 2021-08-19 | B Purchase |
Chairman of the Board of Directors Director |
66,855
285.68
SEK2,685,328 |
66,855 | 285.68 | SEK2,685,328 | |
| 2021-07-16 | 2021-07-16 | B Purchase |
Member of the Board of Directors Director |
100,000
3.03
SEK302,624 |
100,000 | 3.03 | SEK302,624 | |
| 2021-07-14 | 2021-07-14 | B Purchase |
Chief Financial Officer (CFO) Through a closely affiliated person Officer |
20,000
2.91
SEK58,200 |
20,000 | 2.91 | SEK58,200 | |
| 2021-07-14 | 2021-07-13 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
41,000
2.96
SEK121,370 |
41,000 | 2.96 | SEK121,370 | |
| 2021-07-09 | 2021-07-08 | B Purchase |
Member of the Board of Directors Director |
35,000
2.99
SEK104,480 |
35,000 | 2.99 | SEK104,480 | |
| 2021-07-06 | 2021-07-06 | B Purchase |
Chairman of the Board of Directors Director |
100,000
2.86
SEK285,653 |
100,000 | 2.86 | SEK285,653 | |
| 2020-10-14 | 2020-10-13 | B Purchase |
VD |
20,000
4.25
SEK85,000 |
20,000 | 4.25 | SEK85,000 | |
| 2020-10-14 | 2020-10-12 | B Purchase |
Styrelseledamot/suppleant |
30,000
4.36
SEK130,800 |
30,000 | 4.36 | SEK130,800 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
78,370
6.44
SEK504,703 |
78,370 | 6.44 | SEK504,703 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
77,000
6.40
SEK492,724 |
77,000 | 6.40 | SEK492,724 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
77,000
6.32
SEK486,656 |
77,000 | 6.32 | SEK486,656 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
77,000
6.19
SEK476,657 |
77,000 | 6.19 | SEK476,657 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
80,000
6.25
SEK499,614 |
80,000 | 6.25 | SEK499,614 | |
| 2020-06-22 | 2020-06-18 | S Sale |
Board member |
100,000
6.21
SEK620,638 |
100,000 | 6.21 | SEK620,638 | |
| 2019-12-07 | 2019-12-04 | B Purchase |
General manager |
75,984
2.00
SEK151,968 |
75,984 | 2.00 | SEK151,968 | |
| 2019-12-06 | 2019-12-04 | B Purchase |
Board member and acting CEO |
720,000
2.00
SEK1,440,000 |
720,000 | 2.00 | SEK1,440,000 | |
| 2019-12-05 | 2019-12-04 | B Purchase |
Vice VD |
30,000
2.00
SEK60,000 |
30,000 | 2.00 | SEK60,000 | |
| 2019-12-05 | 2019-12-04 | B Purchase |
Styrelseledamot/suppleant |
720,000
2.00
SEK1,440,000 |
720,000 | 2.00 | SEK1,440,000 |
More insider trading research around Oasmia Pharmaceutical AB
